Skip to content
Open access

Genetic and cellular architecture of breast cancer risk across ancestries.

Sep 2026 · JNCI Cancer Spectrum · 0 citations
Medicine

TL;DR

Results indicate substantial cross-ancestry sharing of breast cancer polygenic architecture, highlight a consistent contribution of regulatory variation, and identify convergent cellular contexts that motivate functional follow-up and inform expectations for the transferability and attainable performance of common-variant risk prediction across populations.

Abstract

Background

Breast cancer genome-wide association studies (GWAS) have identified more than 200 susceptibility loci, but most studies are dominated by European and East Asian populations.

Methods

We analyzed breast cancer GWAS summary statistics from African (AFR), East Asian (EAS), European (EUR), and Hispanic/Latina (H/L) samples (159,297 cases and 212,102 controls). We estimated logit-scale SNP-based heritability, polygenicity, and cross-ancestry genetic correlation, partitioned heritability across functional annotations, and integrated GWAS results with the Tabula Sapiens single-cell atlas using scDRS+.

Results

The logit-scale heritability of breast cancer ranged from h2=0.47 (SE = 0.07) in EAS to AFR h2=0.61 (SE = 0.10), with no significant differences across ancestries (p = 0.63). The model-implied number of non-null susceptibility SNPs in the sparse normal-mixture effect-size model also varied from 4,446 (SE = 3,100) in EAS to 8,308 (SE = 2,751) in AFR, but differences were not significant across ancestries (p = 0.55). Cross-sample genetic correlations varied, with the strongest correlation between EUR and EAS (ρ=0.79, SE = 0.08) and weakest between AFR and H/L (ρ=0.26, SE = 0.24). Regulatory annotations were enriched for breast cancer heritability across samples. Integration with single-cell expression profiles implicated ancestry-shared associations with innate immune, secretory epithelial, and stromal cell types.

Conclusion

These results indicate substantial cross-ancestry sharing of breast cancer polygenic architecture, highlight a consistent contribution of regulatory variation, and identify convergent cellular contexts that motivate functional follow-up and inform expectations for the transferability and attainable performance of common-variant risk prediction across populations.

Read PDF

Similar papers

Open access Sep 2026

Genotype-by-regional ancestry proxy interactions at 8q24 reveal association heterogeneity in prostate cancer risk.

The 8q24 region is a major prostate cancer susceptibility locus, but variant effects may differ across ancestry-associated haplotype contexts. We analyzed whole genome sequencing and electronic health record data from 166,155 male participants in the NIH All of Us Research Program (10,166 cases and 155,989 controls). A...

G. J. Kim · 0 citations
Open access Sep 2026

Cross-population genome-wide meta-analysis identifies pancreatic cancer susceptibility loci and etiologic pathways

A cross-population genome-wide association meta-analysis of 11 GWAS summary-statistic datasets comprises 20,120 pancreatic cancer cases and 1,446,192 controls genetically similar to European or East Asian reference populations refine the genetic architecture of pancreatic cancer and provide insights into candidate gene...

Shuai Yuan, Teng-Fei Li, Meng Zhang et al. · 0 citations
Open access Sep 2026

Integrative analysis of immune-cell eQTLs and Mendelian randomization identifies genetically supported genes associated with breast cancer susceptibility.

Breast cancer susceptibility loci identified by genome-wide association studies (GWAS) have revealed extensive genetic contribution to disease risk, yet the genes and immune regulatory mechanisms underlying these associations remain largely unresolved. Here, we integrated immune-cell-specific cis-eQTL data with breast...

Fu-Lei Han, Rong-Rong Zhao, Hai-Ning Yu et al. · 0 citations
Open access Sep 2026

A Genome-wide Genetic Data Resource for the 45 and Up Study

Polygenic risk scores (PGS) for four most common cancers showed predictive performance broadly consistent with previous studies, including association between PGS and earlier age at prostate cancer diagnosis, and no meaningful differences in cancer stage at diagnosis by PGS.

H. M. Tanha, D. Goldsbury, R. Parker et al. · 0 citations
Open access Jan 2026

From Germline Variants to Tumor Outcome: GWAS‐Based Functional Genomics Prioritizes Colorectal Cancer Susceptibility Genes and Links SMAD9 to Prognosis

Integrating statistical genetics, regulatory prediction, and locus‐directed experiments prioritized SMAD9, MAP3K2, FADS1, and ACTR1B as CRC susceptibility genes, and placed experimental bounds on the proposed MAP3K2 and ACTR1B mechanisms.

Chengguang Hu, Guang Yang, Han Xiong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.